Qube Research & Technologies (QRT)
SILK

Qube Research & Technologies (QRT)’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-45,857
Closed -$1.24M – 4327
2024
Q2 		$1.24M Sell
45,857
-60,691
-57% -$1.26M ﹤0.01% 1801
2024
Q1 		$1.95M Buy
106,548
+3,393
+3% +$53.8K ﹤0.01% 1777
2023
Q4 		$1.27M Buy
103,155
+51,129
+98% +$480K ﹤0.01% 1789
2023
Q3 		$780K Sell
52,026
-32,729
-39% -$681K ﹤0.01% 1846
2023
Q2 		$2.75M Sell
84,755
-74,377
-47% -$2.72M 0.01% 914
2023
Q1 		$6.23M Buy
159,132
+104,765
+193% +$5.12M 0.03% 606
2022
Q4 		$2.87M Buy
+54,367
New +$2.65M 0.02% 819
2021
Q3 		– Sell
-4,941
Closed -$236K – 2899
2021
Q2 		$236K Sell
4,941
-5,007
-50% -$255K ﹤0.01% 1717
2021
Q1 		$504K Buy
+9,948
New +$553K 0.01% 1174

Other funds holding SILK

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SILK Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 45,857 shares — an estimated $1.24M sold.

Qube Research & Technologies (QRT) first reported a position in SILK in Q1 2021 and held it in 9 quarters. The position peaked at $6.23M in Q1 2023. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 45,857 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $1.24M.
  • Qube Research & Technologies (QRT) first reported a position in Silk Road Medical, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
  • Qube Research & Technologies (QRT)'s Silk Road Medical, Inc. Common Stock position peaked at $6.23M in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.